Palisade Bio (PALI) Return on Sales Growth (3y) (2014 - 2023)
Palisade Bio (PALI) Return on Sales Growth (3y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1,107.00 |
| Sep 30, 2023 | 541.00 |
| Jun 30, 2023 | 559.00 |
| Mar 31, 2023 | 249.00 |
| Sep 30, 2022 | -6,504.00 |
| Jun 30, 2022 | -3,151.00 |
| Mar 31, 2022 | -5,256.00 |
| Dec 31, 2020 | -1,293.00 |
| Sep 30, 2020 | 289.00 |
| Jun 30, 2020 | 1,037.00 |
| Mar 31, 2020 | 1,364.00 |
| Dec 31, 2019 | -201.00 |
| Sep 30, 2019 | 1,189.00 |
| Jun 30, 2019 | 1,413.00 |
| Mar 31, 2019 | 1,652.00 |
| Dec 31, 2018 | 1,193.00 |
| Sep 30, 2018 | 1,429.00 |
| Jun 30, 2018 | 2,171.00 |
| Mar 31, 2018 | 762.00 |
| Dec 31, 2017 | 1,171.00 |